Switch to:
More From Other Websites
10-K for VIVUS, Inc. Feb 27 2015
Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst Blog Feb 26 2015
JPM Securities Picks Through Biotech News For Winners Feb 25 2015
VIVUS Q4 Loss Wider than Expected, Qsymia Disappoints - Analyst Blog Feb 25 2015
Vivus reports 4Q loss Feb 24 2015
Vivus reports 4Q loss Feb 24 2015
VIVUS Inc Earnings Call scheduled for 4:30 pm ET today Feb 24 2015
VIVUS Reports Fourth Quarter and Year-End 2014 Financial Results Feb 24 2015
VIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Feb 24 2015
Q4 2014 Vivus Inc Earnings Release - After Market Close Feb 24 2015
Obesity Drugs: Orexigen Gains Market Share at Expense of Arena, Vivus Feb 20 2015
Activists want 'imminent retirement' of Ariad CEO Feb 20 2015
VIVUS to Present at Upcoming Investor Conference Feb 20 2015
VIVUS to Present at Upcoming Investor Conference Feb 20 2015
VIVUS Announces Date of Fourth Quarter and Year End 2014 Update and Financial Results Conference... Feb 19 2015
VIVUS Announces Date of Fourth Quarter and Year End 2014 Update and Financial Results Conference... Feb 19 2015
VIVUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 29 2015
VIVUS Announces European Approval of SPEDRA Label Amendment; SPEDRA Now First and Only Oral Erectile... Jan 29 2015
VIVUS Announces European Approval of SPEDRA Label Amendment; SPEDRA Now First and Only Oral Erectile... Jan 29 2015
VIVUS INC Files SEC form 8-K, Change in Directors or Principal Officers Jan 27 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK